Evidence map›Paper›PMID 31652643›Full record

ArticleBiomolecules2019

The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents.

Ming-Chi Lai, Ray-Chang Tzeng, Chin-Wei Huang, Sheng-Nan Wu

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Characterization in Potent Modulation on Voltage-Gated NaInternational journal of molecular sciences · 2022
    Article
  9. Zingerone Modulates Neuronal Voltage-Gated NaInternational journal of molecular sciences · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Ming-Chi LaiDepartment of Pediatrics, Chi-Mei Medical Center, Tainan 710, Taiwan. vickylai621@gmail.com.
Ray-Chang TzengDepartment of Neurology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701, Taiwan. tzeng63@yahoo.com.tw.
Chin-Wei HuangDepartment of Neurology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. huangcw@mail.ncku.edu.tw.
Sheng-Nan WuInstitute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. snwu@mail.ncku.edu.tw.
Chi Mei Medical Center · TWNational Cheng Kung University · TWNational Cheng Kung University Hospital · TWTainan Municipal Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perampanel (PER) is a selective blocker of AMPA receptors showing efficacy in treating various epileptic disorders including brain tumor-related epilepsy and also potential in treating motor neuron disease. However, besides its inhibition of AMPA-induced currents, whether PER has any other direct ionic effects in different types of neurons remains largely unknown. We investigated the effects of PER and related compounds on ionic currents in different types of cells, including hippocampal mHippoE-14 neurons, motor neuron-like NSC-34 cells and U87 glioma cells. We found that PER differentially and effectively suppressed the amplitude of voltage-gated Na

Indexed as

AnimalsCell LineHumansMiceNitrilesPotassium Channels, Voltage-GatedPyridonesReceptors, AMPAVoltage-Gated Sodium ChannelsNitrilesperampanelPotassium Channels, Voltage-GatedPyridonesReceptors, AMPAVoltage-Gated Sodium Channelsglioma cellhippocampal cellmotor neuronM-type K+ currentNa+ currentPerampanel

Identifiers

PMID31652643
PMCPMC6843791
OpenAlexW2981715561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.